SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px
Document › Details

Algeta ASA. (8/16/12). "Press Release: Algeta Initiates New R&D Program to Investigate a Targeted Thorium Conjugate (TTC) against Hematological Cancer [Not intended for US media]". Oslo.

Organisations Organisation Algeta ASA (Oslo Stock Exchange: ALGETA)
  Group Bayer (Group)
  Organisation 2 Cobra Biologics Ltd.
  Group Cobra Biologics (Group)
Product Product therapeutic antibody
Persons Person Ramdahl, Thomas (Algeta 201308– COO before CTO before CEO since 2001)
  Person 2 Booth, Mike (Algeta 201110– SVP Communications + Corporate Affairs before Head of Trout International before UBS London)

Record changed: 2015-08-21


Picture [LSUS] – The Business Web Portal 600x60px

More documents for Bayer (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [LSUK] – The Business Web Portal 600x80px

» top